Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

● . . Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares October 10, 2024 9:09 AM EDT | Source: Cardiol Therapeutics Inc. Oakville, Ontario--(Newsfile Corp. - October 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, confirmed today that it has successfu ...